Table 3.
Age- and sex-adjusted mortality rates and HRs for different exposure groups
| Exposure | Person (y) | Death (N) | IR (95% CI) per 100 pys | HR (95% CI) compared with participants without VTE and without cancer | HR (95% CI) compared with participants without VTE and without cancer, after correction for confounders∗ | HR (95% CI) compared with participants with cancer but without VTE | HR (95% CI) compared with participants with cancer but without VTE, after correction for confounders∗ |
|---|---|---|---|---|---|---|---|
| No VTE, no cancer | 1 624 840 | 10 341 | 0.64 (0.62-0.65) | 1 (reference) | 1 (reference) | N/A | N/A |
| VTE | 8993 | 448 | 5.0 (4.6-5.5) | 3.2 (2.9-3.5) | 3.2 (2.9-3.5) | ||
| Cancer | 65 018 | 6002 | 9.2 (9.0-9.5) | 7.2 (7.0-7.4) | 7.2 (6.9-7.4) | 1 (reference) | 1 (reference) |
| Cancer-related VTE | 889 | 403 | 45.3 (41.1-50.0) | 24.6 (22.2-27.2) | 25.4 (22.9-28.1) | 3.4 (3.1-3.8) | 3.5 (3.2-3.9) |
N/A, not available.
∗
Note, extra confounders corrected for were smoking, body mass index, diabetes, and antihypertensive medicine use.